Cargando…

GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives

To date, non-alcoholic fatty liver disease (NAFLD) is the most frequent liver disease, affecting up to 70% of patients with diabetes. Currently, there are no specific drugs available for its treatment. Beyond their anti-hyperglycemic effect and the surprising role of cardio- and nephroprotection, GL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nevola, Riccardo, Epifani, Raffaella, Imbriani, Simona, Tortorella, Giovanni, Aprea, Concetta, Galiero, Raffaele, Rinaldi, Luca, Marfella, Raffaele, Sasso, Ferdinando Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865319/ https://www.ncbi.nlm.nih.gov/pubmed/36675217 http://dx.doi.org/10.3390/ijms24021703

Ejemplares similares

Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
por: Vetrano, Erica, et al.
Publicado: (2023)

Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?
por: Salvatore, Teresa, et al.
Publicado: (2020)

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
por: Salvatore, Teresa, et al.
Publicado: (2022)

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2021)

Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study
por: Caturano, Alfredo, et al.
Publicado: (2023)

Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations
por: Galiero, Raffaele, et al.
Publicado: (2023)

Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
por: Rinaldi, Luca, et al.
Publicado: (2021)

Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination
por: Nevola, Riccardo, et al.
Publicado: (2023)

Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases
por: Salvatore, Teresa, et al.
Publicado: (2019)

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy
por: Galiero, Raffaele, et al.
Publicado: (2020)

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2022)

HCC and Molecular Targeting Therapies: Back to the Future
por: Rinaldi, Luca, et al.
Publicado: (2021)

Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
por: Salvatore, Teresa, et al.
Publicado: (2021)

Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
por: Galiero, Raffaele, et al.
Publicado: (2023)

Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
por: Salvatore, Teresa, et al.
Publicado: (2021)

Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma
por: Nevola, Riccardo, et al.
Publicado: (2023)

Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
por: Caturano, Alfredo, et al.
Publicado: (2023)

Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome
por: Cozzolino, Domenico, et al.
Publicado: (2023)

Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
por: Caturano, Alfredo, et al.
Publicado: (2023)

HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis
por: Nevola, Riccardo, et al.
Publicado: (2023)

Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
por: Salvatore, Teresa, et al.
Publicado: (2022)

GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease
por: Lee, Jinmi, et al.
Publicado: (2012)

Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?
por: Nevola, Riccardo, et al.
Publicado: (2023)

Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2019)

Predictors of early and late hepatocellular carcinoma recurrence
por: Nevola, Riccardo, et al.
Publicado: (2023)

Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2018)

Platypnea-orthodeoxia syndrome in SARS-CoV-2 related ARDS: a case report
por: Aprea, Concetta, et al.
Publicado: (2022)

The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia
por: Galiero, Raffaele, et al.
Publicado: (2022)

The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
por: Salvatore, Teresa, et al.
Publicado: (2021)

Metformin: A Potential Therapeutic Tool for Rheumatologists
por: Salvatore, Teresa, et al.
Publicado: (2020)

Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects
por: Pafundi, Pia Clara, et al.
Publicado: (2021)

Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis
por: Cuomo, Giovanna, et al.
Publicado: (2023)

Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study
por: Galiero, Raffaele, et al.
Publicado: (2022)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study
por: Galiero, Raffaele, et al.
Publicado: (2020)

Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study
por: Pafundi, Pia Clara, et al.
Publicado: (2021)

Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study
por: Nevola, Riccardo, et al.
Publicado: (2023)

Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
por: Palmiero, Giuseppe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pnud6hmuvau8a487aaa6lm5p2s